Accu-Chek Solo and Abbott Acquiring Bigfoot Biomedical

0 Просмотры· 09/19/23
Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
0
В

In this episode, hosts discuss a pair of topics making headlines in recent weeks: the US Food and Drug Administration’s 510(k) clearance for the Accu-Chek Solo micropump system and Abbott’s acquisition of Bigfoot Biomedical.

Показать больше

 0 Комментарии sort   Сортировать по


Следующий